JPS - EU and US Regulations
EU and US Regulations

There is increased call for (further) regulating the pharmaceutical industry. This is evidenced by the recent Sector Enquiry into the Pharmaceutical Sector by the European Commission. This will likely lead to additional legislation and even more complicated regulatory procedures.

In addition, laws such as the US Foreign Corrupt Practices Act, the UK Bribery Act 2010 and the new set of EU rules known as the 'Pharmaceutical Package', which includes the Falsified Medicines Directive, have a growing impact on the world-wide business climate.

JPS legal offers client-focused, tailor-made support to deal with such issues in an efficient, pro-active and professional way.
     Welcome     |     Company     |     Legal     |     Compliance      |     Contact us     |     Disclaimer     
Legal & Compliance
for Life Sciences